Bausch Health Companies Inc. (NASDAQ:BHC)

BRIEF

published on 12/12/2024 at 13:05, 9 days ago

Bausch Health Considers Potential Sale of Bausch + Lomb

Bausch Health Strategic Plans Stock Volatility Sale Rumors Bausch + Lomb
PRESS RELEASE

published on 12/12/2024 at 13:00, 9 days 1 hour ago

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
Bausch Health considers potential sale of subsidiary Bausch + Lomb to complete full separation. Response to CIRO's request regarding market rumors and stock volatility

Bausch Health CIRO Market Rumors Stock Volatility Subidiary Sale
BRIEF

published on 12/05/2024 at 14:05, 15 days 23 hours ago

Second Annual Opioid-Induced Constipation Awareness Day Recognized

Salix Pharmaceuticals Bausch Health Chronic Pain Opioid-Induced Constipation Awareness Day
PRESS RELEASE

published on 12/05/2024 at 14:00, 16 days ago

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
Bausch Health Companies Inc., Salix Pharmaceuticals, and healthcare organizations join forces for the second annual Opioid-Induced Constipation Awareness Day to raise awareness and support patients affected by OIC

Bausch Health Companies Inc. Healthcare Organizations Awareness Opioid-Induced Constipation Awareness Day OIC
BRIEF

published on 12/02/2024 at 14:05, 18 days 23 hours ago

Bausch Health Appoints New Chief Medical Officer and Head of R&D

Innovation Pharmaceuticals R&D Bausch Health Jonathan Sadeh
PRESS RELEASE

published on 12/02/2024 at 14:00, 19 days ago

Bausch Health Appoints New Chief Medical Officer and Head of R&D
Bausch Health Companies Inc. appoints Jonathan Sadeh M.D., M.Sc as Executive VP, Chief Medical Officer & Head of R&D, emphasizing commitment to innovation & excellence

Innovation Bausch Health Companies Inc. R&D Chief Medical Officer Jonathan Sadeh
BRIEF

published on 11/18/2024 at 14:05, 1 month 2 days ago

Bausch Health's CABTREO Receives Positive Reimbursement Endorsements in Canada

Bausch Health Dermatology Acne Treatment Canada Drug Approval Reimbursement Endorsement
PRESS RELEASE

published on 11/18/2024 at 14:00, 1 month 3 days ago

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Bausch Health, Canada announces positive reimbursement recommendations for new acne treatment CABTREO, the first triple-combination topical therapy approved in Canada

Bausch Health CABTREO Canada Acne Treatment Reimbursement
BRIEF

published on 10/30/2024 at 21:10, 1 month 21 days ago

Bausch Health Reports Strong Third Quarter 2024 Results

Adjusted EBITDA Revenue Growth Financial Performance Bausch Health Quarterly Results
PRESS RELEASE

published on 10/30/2024 at 21:05, 1 month 21 days ago

Bausch Health Announces Third Quarter 2024 Results
Bausch Health Companies Inc. reports sixth consecutive quarter of revenue and Adjusted EBITDA growth. Q3 revenues reach $2.51 billion, up 12%. GAAP Net Loss at $85 million. Raised full-year 2024 guidance

Adjusted EBITDA Revenue Growth Bausch Health Full-year Guidance Q3 Financial Results

Published on 12/21/2024 at 01:30, 12 hours 32 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 32 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 13 hours 57 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 14 hours 2 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 32 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 13 hours 11 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 13 hours 17 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 18 hours 51 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 19 hours 6 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 20 hours 2 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 44 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 20 hours 2 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 20 hours 7 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 1 day ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News